Journal Mobile Options
Table of Contents
Vol. 46, No. 2, 2002
Issue release date: October 2002
Neuropsychobiology 2002;46:76–84

Innate Immunity Associated with Inflammatory Responses and Cytokine Production against Common Dietary Proteins in Patients with Autism Spectrum Disorder

Jyonouchi H. · Sun S. · Itokazu N.
Department of Pediatrics, University of Minnesota, Minneapolis, Minn., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objectives: Children with autism spectrum disorder (ASD) frequently reveal various gastrointestinal (GI) symptoms that may resolve with an elimination diet along with apparent improvement of some of the behavioral symptoms. Evidence suggests that ASD may be accompanied by aberrant (inflammatory) innate immune responses. This may predispose ASD children to sensitization to common dietary proteins (DP), leading to GI inflammation and aggravation of some behavioral symptoms. Methods: We measured IFN-γ, IL-5, and TNF-α production against representative DPs [gliadin, cow’s milk protein (CMP), and soy] by peripheral blood mononuclear cells (PBMCs) from ASD and control children [those with DP intolerance (DPI), ASD siblings, and healthy unrelated children]. We evaluated the results in association with proinflammatory and counter-regulatory cytokine production with endotoxin (LPS), a microbial product of intestinal flora and a surrogate stimulant for innate immune responses. Results: ASD PBMCs produced elevated IFN-γ and TNF-α, but not IL-5 with common DPs at high frequency as observed in DPI PBMCs. ASD PBMCs revealed increased proinflammatory cytokine responses with LPS at high frequency with positive correlation between proinflammatory cytokine production with LPS and IFN-γ and TNF-α production against DPs. Such correlation was less evident in DPI PBMCs. Conclusion: Immune reactivity to DPs may be associated with apparent DPI and GI inflammation in ASD children that may be partly associated with aberrant innate immune response against endotoxin, a product of the gut bacteria.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Benlounes N, Candalh C, Matarazzo P, Dupont C, Heyman M: The time-course of milk antigen-induced TNF-α secretion differs according to the clinical symptoms in children with cow’s milk protein. J Allergy Clin Immunol 1999;104:863–869.
  2. Sampson HA, Anderson JA: Summary and recommendations: Classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children. J Ped Gastroenterol Nutr 2000;30:S87–S94.
  3. Sicherer SH: Food protein-induced enterocolitis syndrome: Clinical perspectives. J Ped Gastroenterol Nutr 2000;30:S45–S49.
  4. Furlano R, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz MM, Forbes A, Wakefield AJ, Walker-Smith JA, Murch SH: Colonic CD8 and γδ T-cell infiltration with epithelial damage in children with autism. J Pediatr 2001;138:3663–3672.
  5. Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomer SM, Davies S, O’Leary JJ, Berelowitz M, Walker-Smith JA: Enterocolitis in children with developmental disorders. Am J Gastroenterol 2000;95:2285–2295.
  6. Medzhitov R, Janeway C Jr: Innate immunity. New Engl J Med 2000;343:338–344.
  7. Ulevitch RJ: Molecular mechanisms of innate immunity. Immunol Res 2000;21:49–54.
  8. Wright SD: Toll, a new piece in the puzzle of innate immunity. J Exp Med 1999;189:605–609.
  9. Jyonouchi H, Sun S, Le H: Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001;120:170–179.
  10. Benlounes N, Dupont C, Candalh C, Blaton MA, Bloom M, Heyman M: Effect of terfenadine on TNF-α release from peripheral blood mononuclear cells during cow’s milk allergy. Clin Exp Allergy 1997;27:942–948.

    External Resources

  11. Dupont C, Heyman M: Food protein-induced enterocolitis syndrome: Laboratory perspectives. J Ped Gastroenterol Nutr 2000;30:S50–S57.
  12. Nagata S, McKenzie C, Pender SLF, Bajaj-Elliot M, Fairclough PD, Walker-Smith JA, Monteleone G, MacDonald TT: Human Peyer’s patch T cells are sensitized to dietary antigens and display a Th cell type 1 cytokine profile. J Immunol 2000;165:5315–5321.

    External Resources

  13. Swain SL: Helper T cell differentiation. Curr Opin Immunol 1999;11:180–185.
  14. Ono SJ: Molecular genetics of allergic diseases. Annu Rev Immunol 2000;8:347–366.

    External Resources

  15. Bregenholt S, Claesson MH: Increased intracellular Th1 cytokines in SCID mice with inflammatory bowel disease. Eur J Immunol 1998;28:379–389.
  16. Trobonjaca Z, Leithauder F, Moller P, Bluethmann H, Koezuka Y, MacDonald HR, Reimann J: MHC-II-independent CD4+ T cells induce colitis in immunodeficient RAG–/–. J Immunol 2001;166:3804–3812.
  17. Heyman M, Darmon N, Dupont C, Dugas B, Hirribaen A, Blaton MA, Desjeux JF: Mononuclear cells from infants allergic to cow’s milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology 1994;106:1514–1523.
  18. Jyonouchi H, Sun S, Rimell FL: Cytoline production by sinus lavage, bronchial lavage, and blood mononuclear cells in chronic rhinosinusitis with or without atopy. Arch Otolaryngol Head Neck Surg 2000;126:522–528.
  19. D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, Cardi E, Giardini O: Abnormal intestinal permeability in children with autism. Acta Pediatr 1996;85:1076–1079.
  20. Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tioson JT: Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 1999;135:559–563.
  21. Adams RB, Planchon SM, Roche JK: IFN-γ modulation of epithelial barrier function: Time course, reversibility, and site of cytokine binding. J Immunol 1993;150:2356–2363.
  22. Terpend K, Boisgerault F, Blanton MA, Desjeux JF, Heyman M: Protein transport and processing by human HT29-19A intestinal cells: Effect of interferon-gamma. Gut 1998;42:538–545.
  23. Mariani P, Bachetoni A, D’Alessandro M, Lomanto D, Mazzocchi P, Speranza V: Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn’s disease. Digest Dis Sci 2000;45:2029–2035.
  24. Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS: Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology 1999;38:202–213.
  25. Flavell RA: The molecular basis of T cell differentiation. Immunol Res 1999;19:159–168.

    External Resources

  26. Gupta S, Aggarwal S, Rashanaravan B, Lee T: Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998;85:106–109.
  27. Mohankumar SMJ, Mohankumar, PS, Quadri SK: Specificity of interleukin-1β-induced changes in monoamine concentrations in hypothalamic nuclei: Blockade by interleukin-1 receptor antagonist. Brain Res Bull 1998;47:29–34.

    External Resources

  28. Mossner R, Heils A, Strober G, Okladnova O, Daniel S, Lesch KP: Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem Int 1998;33:251–254.
  29. Barkhudaran N, Dunn AJ: Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis. Neurochem Res 1999;24:1169–1180.
  30. Dunn AJ, Wang J, Ando T: Effects of cytokines on cerebral neurotransmission; comparison with the effects of stress. Adv Exp Med Biol 1999;461:117–127.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50